WOCKHARDT
Back to Balance Sheet
|
WOCKHARDT Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹2,791 Cr | ₹3,435 Cr | ₹3,207 Cr | ₹3,121 Cr | ₹3,497 Cr |
What is the latest Total Current Liabilities ratio of WOCKHARDT ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹2,791 Cr |
Mar2023 | ₹3,435 Cr |
Mar2022 | ₹3,207 Cr |
Mar2021 | ₹3,121 Cr |
Mar2020 | ₹3,497 Cr |
How is Total Current Liabilities of WOCKHARDT Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹2,791 Cr | -18.75 | |
Mar2023 | ₹3,435 Cr | 7.11 | |
Mar2022 | ₹3,207 Cr | 2.76 | |
Mar2021 | ₹3,121 Cr | -10.76 | |
Mar2020 | ₹3,497 Cr | - |
Compare Total Current Liabilities of peers of WOCKHARDT
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WOCKHARDT | ₹24,463.6 Cr | 2.7% | 22.1% | 182.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,076.0 Cr | 0.3% | -4.9% | 15.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,924.0 Cr | 0.2% | 10% | 53.5% | Stock Analytics | |
CIPLA | ₹121,456.0 Cr | 2.3% | 1.1% | 2.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,197.0 Cr | 5.7% | 15% | 11.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,761.0 Cr | 0.8% | -0.9% | 17.4% | Stock Analytics |
WOCKHARDT Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WOCKHARDT | 2.7% |
22.1% |
182.1% |
SENSEX | 0.9% |
1.8% |
11.1% |
You may also like the below Video Courses